Staphylococci bacterial infections are a major cause of potentially deadly community and healthcare-associated infections. Staph is a highly adaptable bacteria that is becoming resistant to nearly all known antibiotics and causes severe and deadly infections in the hospital and the community. Our multi-targeted S. aureus vaccine, PentaStaph, intends to neutralize the major toxin arsenal that debilitates our immunity and elicit antibodies that allow our immune system to recognize and kill this invading organism. The PentaStaph approach is the smart way to combat this serious emerging Staphylococcus problem in the hospital and the community.
Matt Hohenboken
M.D., Ph.D., Executive Director, Clinical Research
|